who discovered glp 1 should win a Nobel for the science of the Ozempic revolution? History of glucagon-like peptide-1 receptor

A JAMA Network Open retrospective cohort study of 125,474 adults with overweight or obesity: Patients with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Patients without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two Nearly 85% of patients without diabetes stopped taking GLP-1s within two years

The good news: Wegovy-related fatigue is generally mild and often temporary

[DOI] [PubMed] [Google Scholar] 12.Cheng W., Gonzalez I., Pan W., Tsang A.H., Adams J., Ndoka E

The resistant starches, diverse fibres and polyphenol antioxidants in Pendulum Gut Fuel nourish beneficial gut bacteriaand because it blends seamlessly into everyday foods, it turns virtually any meal into a superfood that closes the fibre gap and supports the microbiome

There is no robust evidence base guiding treatment in the 25-27 range, and essentially no data for BMIs below 25